We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Ranbaxy may join the bidding war for Merck KGaA’s generic drugs division, according to a company source who confirmed reports of the generic firm’s interest in acquiring the billion-dollar division.
Hong Kong’s Medical Device Control Office (MDCO) has issued a third reference document supporting the establishment of a conformity assessment process for medical devices.
Economic growth and a desire to improve the overall quality of and access to healthcare services should make Latin America an enticing market for medical device manufacturers.
Pfizer recently updated physician labeling in the European Union (EU) for antibacterial agent Zyvox to reflect safety restrictions for use in patients with serious catheter-related bloodstream infections, the company told DID.
Brazil’s Sanitary Surveillance Agency (ANVISA) has released a draft technical regulation establishing a mandatory certification program for all electric-powered devices used to monitor, diagnose or treat health conditions in humans.
The Asian Harmonization Working Party (AHWP) has released a draft document aimed at establishing a framework for reporting and sharing adverse event information involving medical devices in its 13 member economies.
Australia’s Therapeutic Goods Administration (TGA) has published a list of reasons medical device applications to the Australian Register of Therapeutic Goods (ARTG) are denied in hopes of curbing the high number of rejections.
A little more than week after Ranbaxy Laboratories launched generic Lipitor in Denmark, Pfizer won a preliminary injunction blocking its sale, a Pfizer spokesman said.